InvestorsHub Logo
Followers 276
Posts 32702
Boards Moderated 0
Alias Born 11/14/2013

Re: ATLnsider post# 593884

Wednesday, 05/17/2023 11:12:57 AM

Wednesday, May 17, 2023 11:12:57 AM

Post# of 701145
Her October 2022 speech about the combination trial did not omit discussing poly iclc, she simply strongly inferred it was the next component to be added to that “current” combination (spore) trial (after it had started with DCVax-l and Keytruda). Following that, the intention is to add csf1r. That then will be the complete combination.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News